These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 29052237)

  • 1. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.
    Kump P; Wurm P; Gröchenig HP; Wenzl H; Petritsch W; Halwachs B; Wagner M; Stadlbauer V; Eherer A; Hoffmann KM; Deutschmann A; Reicht G; Reiter L; Slawitsch P; Gorkiewicz G; Högenauer C
    Aliment Pharmacol Ther; 2018 Jan; 47(1):67-77. PubMed ID: 29052237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
    Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.
    Vermeire S; Joossens M; Verbeke K; Wang J; Machiels K; Sabino J; Ferrante M; Van Assche G; Rutgeerts P; Raes J
    J Crohns Colitis; 2016 Apr; 10(4):387-94. PubMed ID: 26519463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
    Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study.
    van Lingen E; Nooij S; Terveer EM; Crossette E; Prince AL; Bhattarai SK; Watson A; Galazzo G; Menon R; Szabady RL; Bucci V; Norman JM; van der Woude CJ; van der Marel S; Verspaget HW; van der Meulen-de Jong AE; Keller JJ
    J Crohns Colitis; 2024 Sep; 18(9):1381-1393. PubMed ID: 38572716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
    Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
    Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
    Ishikawa D; Sasaki T; Takahashi M; Kuwahara-Arai K; Haga K; Ito S; Okahara K; Nakajima A; Shibuya T; Osada T; Hiramatsu K; Watanabe S; Nagahara A
    Inflamm Bowel Dis; 2018 Nov; 24(12):2590-2598. PubMed ID: 30124831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
    Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
    BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
    Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study.
    Tian Y; Zhou Y; Huang S; Li J; Zhao K; Li X; Wen X; Li XA
    BMC Gastroenterol; 2019 Jul; 19(1):116. PubMed ID: 31272391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Ishikawa D; Sasaki T; Osada T; Kuwahara-Arai K; Haga K; Shibuya T; Hiramatsu K; Watanabe S
    Inflamm Bowel Dis; 2017 Jan; 23(1):116-125. PubMed ID: 27893543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.
    Fuentes S; Rossen NG; van der Spek MJ; Hartman JH; Huuskonen L; Korpela K; Salojärvi J; Aalvink S; de Vos WM; D'Haens GR; Zoetendal EG; Ponsioen CY
    ISME J; 2017 Aug; 11(8):1877-1889. PubMed ID: 28398347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis.
    Rees NP; Shaheen W; Quince C; Tselepis C; Horniblow RD; Sharma N; Beggs AD; Iqbal TH; Quraishi MN
    EBioMedicine; 2022 Jul; 81():104088. PubMed ID: 35660786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone.
    Leibovitzh H; Sarbagili Shabat C; Hirsch A; Zittan E; Mentella MC; Petito V; Cohen NA; Ron Y; Fliss Isakov N; Pfeffer J; Yaakov M; Fanali C; Turchini L; Masucci L; Quaranta G; Kolonimos N; Godneva A; Weinberger A; Scaldaferri F; Maharshak N
    J Crohns Colitis; 2024 Oct; 18(10):1606-1614. PubMed ID: 38720628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated fecal microbiota transplantation in a child with ulcerative colitis.
    Shimizu H; Arai K; Abe J; Nakabayashi K; Yoshioka T; Hosoi K; Kuroda M
    Pediatr Int; 2016 Aug; 58(8):781-5. PubMed ID: 27324973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.
    Quraishi MNN; Yalchin M; Blackwell C; Segal J; Sharma N; Hawkey P; McCune V; Hart AL; Gaya D; Ives NJ; Magill L; Loi S; Hewitt C; Gerasimidis K; Loman NJ; Hansen R; McMullan C; Mathers J; Quince C; Crees N; Iqbal T
    BMJ Open; 2019 Nov; 9(11):e030659. PubMed ID: 31719078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.